Plasmodium falciparum and Schistosoma mansoni coinfection and the side benefit of artemether-lumefantrine in malaria patients

Journal of Infection in Developing Countries

Volumn 7, Issue 6, 2013, Pages 468-474

  Abay, Solomon M ^a   Tilahun, Mulugeta ^a   Fikrie, Nigus ^a   Habtewold, Abiy ^a  

^a ADDIS ABABA UNIVERSITY   (Ethiopia)

Author keywords

Artemether lumefantrine; Ethiopia; P. falciparum; S. mansoni; Schistosomiasis and malaria co infection

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL;

ADOLESCENT; ADULT; ARTICLE; CHILD; DISEASE ASSOCIATION; FEMALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; MIXED INFECTION; PRESCHOOL CHILD; PROSPECTIVE STUDY; SCHISTOSOMIASIS MANSONI; TREATMENT RESPONSE; VIRUS LOAD;

ADOLESCENT; ADULT; ANIMALS; ANTHELMINTICS; ANTIMALARIALS; ARTEMISININS; CHILD; COINFECTION; DRUG COMBINATIONS; ETHANOLAMINES; ETHIOPIA; FECES; FEMALE; FLUORENES; HUMANS; MALARIA, FALCIPARUM; MALE; MIDDLE AGED; PARASITE EGG COUNT; PLASMODIUM FALCIPARUM; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; YOUNG ADULT;

PLASMODIUM FALCIPARUM; SCHISTOSOMA; SCHISTOSOMA MANSONI;

EID: 84879174350     PISSN: 20366590     EISSN: 19722680     Source Type: Journal    
DOI: 10.3855/jidc.2658     Document Type: Article

References (30)

1. Deressa W, Chibsa S., Olana D (2004) The distribution and magnitude of malaria in Oromia, Ethiopia. Ethopia J Health Dev 18: 164-170
2. Senay G, Verdin J (2005) Developing a malaria early warning system for Ethiopia. Twenty-fifth annual ESRI international user conference paper No. UC2409.
3. Snow R, Guerra C, Noor A (2005) The global distribution of clinical episodes of Plasmodium falciparum malaria. Nat 434: 214-217.
4. Shu-hua X, Utzinger J, Chollet J (2006) Effect of artemether administered alone or in combination with praziquantel to mice infected with Plasmodium berghei or Schistosoma mansoni or both. Intern J Parasitol 36: 957-964.
5. FMOH (Federal minister of health) (2007) Ethiopia National Malaria Indicator Survey.
6. Erko B, Abebe F, Berhe N (2006) Control of Schistosoma mansoni by soap berry endod (Phytolocca Dodecandra) in Wollo, North Eastern Ethiopia: post-intervention prevalence. East Afr Med J 79: 198-201.
7. Doenhoff M, Cioli D, Utzinger J (2008) Praziquantel: mechanism of actions resistance and new derivative for schistosomiasis. Curr. Opin Infec Dis 21: 659-667.
8. Cioli D and Pica-Mattoccia L (2003) Praziqantel. Parasitol Res1: 3-9.
9. William S, Botros S, Ismail M (2001) Praziquantel-induced tegumental damage in vitro is diminished in schistosomes derived from praziquantel-resistant infections. Parasitolo 1: 63-66.
10. Smail J, Metwally A, Farghaly A (1996) Characterization of isolates of Schistosoma mansoni from Egyptian villagers that tolerate high doses of praziquantel. Am J Trop Med Hyg 55: 214-218.
11. Meshnick S, Taylor T, Kamchonwongpaisan S (1996) Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy. Micro Rev 60: 301-315.
12. Le W, You J, Yang Y (1982) Studies on the efficacy of artemether in experimental schistosomiasis. Acta Pharm Sin 17: 187-193.
13. Adam I, Elhardello A., Elhadi O, Abdalla E, Elmardi KA, Jansen FH (2008) The antischistosomal efficacies of artesunate-sulfamethoxypyrazine-pyrimethaminc and artemether-lumefantrine administered as treatment for uncomplicated, Plasmodium falciparum malaria. Ann Trap Med Parasitol 102: 39-44.
14. Xiao S, Chollet J, Utzinger J (2001) Artemether administered together with haemin damages schistosomes in vitro. Trans R Soc Trop Med Hyg 95: 67-71.
15. CSA (Central statistical agency) (2005) National Statistics Agency of Ethiopia.
16. Abeku T, Van Oortmarssen G, Borssboom G (2003) Spatial and temporal variations of malaria epidemic risk in Ethiopia: factors involved and implications. Acta trop 7: 331-340.
17. WHO (World Health Organization) (1991) Basic laboratory methods in medical parasitology. Geneva. Available at http://whqlibdoc.who.int/publications/9241544104_(part1).pdf. Last accessed June 2013.
18. Martin J, Naftale K, Paulo M (2007) A case of Schistosoma mansoni infection treated during the prepatent period. Nat clin pract gastroenterol hepatol 95: 112-115.
19. Ebrahim A, El-Morshedy H, Omer E, El-Daly S, Barakat R (1997) Evaluation of the Kato-Katz thick smear and formol ether sedimentation techniques for quantitative diagnosis of Schistosoma mansoni infection. Am J Trop Med Hyg 57: 706-708.
20. Utzinger J, Booth M, N'Goran EK, Müller I, Tanner M, Lengeler C. (2001) Relative contribution of day-to-day and intra-specimen variation in faecal egg counts of Schistosoma mansoni before and after treatment with praziquantel. Parasitol 122: 537-544.
21. Mazigo H, Waihenya R, Lwambo N (2010) Co-infection with Plasmodium falciparum, Schistosoma mansoni and intestinal helminthes among schoolchildren in endemic areas of northwestern Tanzania. Parasit vectors 3: 44.
22. WHO (2002) WHO expert committee report on the prevention and control of schistosomiasis and soil-transmitted, 2001. Geneva. Available at http://apps.who.int/iris/bitstream/10665/42588/1/WHO_TRS_912.pdf. Last accessed June 2013.
23. WHO (2006) Scientific working group report on schistosomiasis, 14-16 November 2005. Geneva. http://whqlibdoc.who.int/hq/2006/TDR_SWG_07_eng.pdf
24. Gazzinelli A, Velasquez-Melendez G, Crawford S (2006) Socioeconomic determinants of Schistosomiasis in a poor area in Brazil. Acta Trop 99: 260-270.
25. Ximenes R, Southgate B, Smith PG, Neto LG (2003) Socioeconomic determinants of schistosomiasis in an urban area in the Northeast of Brazil. Pan Am J Public Health 14: 409-421.
26. Jacob G, Wakninea J, Nicholas M (2006) Current perspectives on the mechanism of action of artemisinins. Internl J Parasitol 36: 1427-1441.
27. Utzinger J, N'Goran NK, N'Dri A, Lengeler C, Xiao S, Tanner M. (2000) Oral artemether for prevention of Schistosoma mansoni infection: randomised controlled trial. Lancet 355: 1320-1325.
28. Obonyo CO, Muok EMO, Mwinzi PNM (2010) Efficacy of artesunate with sulfalene plus pyrimethamine versus praziquantel for treatment of Schistosoma mansoni in Kenyan children: an open-lable, randomised controlled trial. Lancet Infect Dis 10: 603-611
29. Keiser J, N'Guessan NA, Adoubryn KD, Silué KD Vounatsou P, Hatz C, Utzinger J, N'Goran EK. (2010) Efficacy and safety of mefloquine, artesunate, mefloquine-artesunate, and praziquantel against Schistosoma haematobium: randomized, exploratory open-label trial. Clin Infect Dis 50: 1205-1213.
30. Boulanger D, Dieng Y, Cisse B, Remoue F, Capuano F, Dieme JL, Ndiaye T, Sokhna C, Trape JF, Greenwood B, Simondon F (2007) Antischistosomal efficacy of artesunate combination therapies administered as curative treatments for malaria attacks. Trans R Soc Trop Med Hyg 101: 113-116.